Transgenic mice that overexpress the HER-2 gene’s tyrosine phosphorylation show delayed tumor development when genistein is given as an oral supplement, according to a study published just recently by the group Sakla et al. This shows that it may have an anti-cancer role in breast cancer chemotherapy [91]. Here, ERBB2 is linked to breast cancer.